The Centers for Disease Control and Prevention (CDC) began sounding the alarm about a potential rise in mpox (formerly monkeypox) outbreaks this summer, just days before publishing studies suggesting that two doses of Bavarian Nordic’s Jynneos vaccine, rather than one, offer “real-world” protection.
The World Health Organization (WHO) on May 11 ended the global health emergency for mpox — less than a week after it ended the COVID-19 emergency.
But on May 15, the CDC issued a health alert, warning that although mpox cases had declined since peaking last August, “the outbreak is not over.”
The alert informed clinicians and public health agencies that the CDC and local partners were investigating a cluster of mpox cases in the Chicago area, where 12 confirmed and one probable case of mpox had been reported to the Chicago Department of Public Health between April 17 and May 5…
childrenshealthdefense.org 
